Citation Impact
Citing Papers
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
2012 StandoutScience
A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
2016 Standout
Changes in medical management and colectomy rates: a population‐based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963‐2010
2017
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Colonic bacterial composition in Parkinson's disease
2015 Standout
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
TEER Measurement Techniques for In Vitro Barrier Model Systems
2015 Standout
Culture Period-Dependent Change of Function and Expression of ATP-Binding Cassette Transporters in Caco-2 Cells
2009
Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as anin vivoinhibitor of BCRP
2012
The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
2018 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
The Role of Short-Chain Fatty Acids in Health and Disease
2014 Standout
Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis
2011
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Type I interferons in Sjögren's syndrome
2012
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
2013
Burden of liver diseases in the world
2018 Standout
Sex Differences in Pharmacokinetics and Pharmacodynamics
2009
Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines
2007
Macrophages in immunoregulation and therapeutics
2023 Standout
Clinical characteristics and treatment of inflammatory bowel disease: A comparison of Eastern and Western perspectives
2014
Systemic sclerosis
2017 Standout
Sex bias in neuroscience and biomedical research
2010 Standout
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011
2013
Pharmacology and therapeutic potential of interferons
2012
Epidemiology and risk factors for IBD
2015 Standout
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
2011
Prevalence of Muscular Dystrophies: A Systematic Literature Review
2014 Standout
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
2021
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
The burden of inflammatory bowel disease in Europe
2013
Crohn's disease
2016 Standout
Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation
2013
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Microfluidic organs-on-chips
2014 Standout
Coexistence of passive and carrier-mediated processes in drug transport
2010
Regulation of Renal Organic Anion Transporter 3 (SLC22A8) Expression and Function by the Integrity of Lipid Raft Domains and their Associated Cytoskeleton
2013 Standout
Small intestinal bacterial overgrowth syndrome
2010
The myotonic dystrophies: diagnosis and management
2010
Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology
2008
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Registers of the Swedish total population and their use in medical research
2016 Standout
Intestinal permeability in cirrhotic patients with and without ascites
2005
Global burden of liver disease: 2023 update
2023 Standout
Ulcerative colitis
2016 Standout
REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATION
2007
Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
2014
Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe
2014
The type I interferon system in the etiopathogenesis of autoimmune diseases
2011
Ulcerative colitis
2020 Standout
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water
2019
Decision trees to characterise the roles of permeability and solubility on the prediction of oral absorption
2014
A Unifying Hypothesis for Scleroderma: Identifying a Target Cell for Scleroderma
2010
Metabolism and Transport of the Citrus Flavonoid Hesperetin in Caco-2 Cell Monolayers
2008
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
2016
The global burden of IBD: from 2015 to 2025
2015 Standout
Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
2016
Glutathione: Overview of its protective roles, measurement, and biosynthesis
2008 Standout
Epidemiology of Inflammatory Bowel Disease in Québec
2014
European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly: Table 1.
2016
Gene expression profiling offers insights into the role of innate immune signaling in SSc
2015
Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome
2009
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Differential protein abundance of a basolateral MCT1 transporter in the human gastrointestinal tract
2016
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Hypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension
2014
Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations
2010
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
2013
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
2011
Association of Interferon‐ and Transforming Growth Factor β–Regulated Genes and Macrophage Activation With Systemic Sclerosis–Related Progressive Lung Fibrosis
2013
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Gastrointestinal manifestations of systemic sclerosis
2016
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Drug Resistance in Cancer: An Overview
2014 Standout
Works of Anders Rönnblom being referenced
Efflux transporters in ulcerative colitis
2006
Gastric emptying in myotonic dystrophy
2002
Mechanisms of diarrhoea in myotonic dystrophy
1998
Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005–2009 — Results from the IBD Cohort of the Uppsala Region (ICURE)
2013
Incidence and clinical course of Crohn's disease during the first year — Results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005–2009
2013
Ulcerative colitis in the county of Uppsala 1945–2007
2010
Type I interferon system activation and association with disease manifestations in systemic sclerosis
2010
Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells
2006
Gastrointestinal Symptoms in Myotonic Dystrophy
1996
Physiological and structural anorectal abnormalities in patients with systemic sclerosis and fecal incontinence
2014
Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity
2008
Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity
2003
Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study
2009
Different regulation of eosinophil activity in Crohn’s disease compared with ulcerative colitis
2008
Appearance of hepatobiliary diseases in a population‐based cohort with inflammatory bowel diseases (I nflammatory B owel D isease C ohort of the U ppsala R egion)
2015
Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005–2009*
2016